Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (599) 599
life sciences & biomedicine (593) 593
humans (517) 517
male (410) 410
female (407) 407
adult (339) 339
infectious diseases (336) 336
sustained virological response (313) 313
middle aged (311) 311
treatment outcome (240) 240
hiv infections - drug therapy (214) 214
hepatitis c (204) 204
hepatitis c virus (204) 204
viral load (204) 204
antiviral agents - therapeutic use (198) 198
virological failure (195) 195
antiviral agents (186) 186
gastroenterology & hepatology (182) 182
hiv (182) 182
hepatitis c, chronic - drug therapy (174) 174
virology (173) 173
interferon (148) 148
drug therapy, combination (147) 147
hiv infections - virology (134) 134
genotype (127) 127
human immunodeficiency virus--hiv (124) 124
aged (123) 123
biological and medical sciences (122) 122
drug therapy (122) 122
hepatitis (121) 121
medical sciences (121) 121
immunology (120) 120
antiretroviral therapy (117) 117
ribavirin (117) 117
health aspects (113) 113
hepacivirus - genetics (112) 112
anti-hiv agents - therapeutic use (109) 109
ribavirin - therapeutic use (109) 109
analysis (103) 103
care and treatment (100) 100
viral diseases (100) 100
treatment failure (97) 97
interferon-alpha - therapeutic use (96) 96
microbiology (96) 96
human viral diseases (95) 95
antiretroviral drugs (93) 93
highly active antiretroviral therapy (90) 90
cd4 lymphocyte count (89) 89
drug resistance (89) 89
retrospective studies (89) 89
rna, viral - blood (86) 86
biological response modifiers (85) 85
risk factors (81) 81
patients (79) 79
virus diseases (79) 79
pharmacology. drug treatments (76) 76
hepatitis c, chronic - virology (75) 75
young adult (75) 75
aids/hiv (74) 74
cohort studies (73) 73
genetic aspects (72) 72
virological response (72) 72
antibiotics. antiinfectious agents. antiparasitic agents (71) 71
antiviral agents - administration & dosage (69) 69
polyethylene glycols - therapeutic use (69) 69
time factors (67) 67
pharmacology & pharmacy (66) 66
prospective studies (66) 66
drug resistance, viral (65) 65
mutation (65) 65
hepacivirus - drug effects (64) 64
liver (64) 64
adolescent (63) 63
chronic hepatitis c (63) 63
hiv infection (63) 63
cirrhosis (61) 61
research (61) 61
antiretroviral therapy, highly active (56) 56
hepatitis c - drug therapy (55) 55
hiv-1 - drug effects (55) 55
infections (51) 51
viral diseases of the lymphoid tissue and the blood. aids (51) 51
viral load - drug effects (51) 51
hiv infections - immunology (50) 50
gastroenterology and hepatology (48) 48
ribavirin - administration & dosage (47) 47
sustained virologic response (47) 47
viruses (47) 47
recombinant proteins - therapeutic use (46) 46
follow-up studies (44) 44
genotypes (44) 44
liver cirrhosis (44) 44
patient outcomes (44) 44
hiv-1 - genetics (43) 43
digestive system diseases (42) 42
protease inhibitors (42) 42
anti-retroviral agents - therapeutic use (41) 41
antiviral agents - adverse effects (41) 41
rna (41) 41
hiv-1 (40) 40
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (779) 779
Portuguese (10) 10
Spanish (9) 9
French (8) 8
Korean (4) 4
German (1) 1
Indonesian (1) 1
Japanese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Increased Virological Failure in Naive HIV-1–Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort
by Casper Rokx and Azzania Fibriani and David A. M. C. van de Vijver and Annelies Verbon and Martin Schutten and Luuk Gras and Bart J. A. Rijnders and AIDS Therapy Evaluation and AIDS Therapy Evaluation in the Netherlands National Observational Cohort and for the AIDS Therapy Evaluation in the Netherlands (ATHENA) National Observational Cohort
Clinical infectious diseases, ISSN 1058-4838, 1/2015, Volume 60, Issue 1, pp. 143 - 153
HIV/AIDS | no | HIV-1 | emtricitabine | virological failure | antiretroviral therapy | lamivudine | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Anti-Retroviral Agents - therapeutic use | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Netherlands - epidemiology | Male | Viral Load | Incidence | HIV-1 - isolation & purification | Treatment Failure | Adult | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Cohort Studies | Prescription drugs | Antiretroviral drugs | Regression analysis | Human immunodeficiency virus--HIV | Failure | Virology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011-2015
by Zhao, Yan and Wu, Zunyou and McGoogan, Jennifer M and Sha, Yiyi and Zhao, Decai and Ma, Ye and Brookmeyer, Ron and Detels, Roger and Montaner, Julio S G
Clinical infectious diseases, ISSN 1058-4838, 01/2019, Volume 68, Issue 1, pp. 43 - 50
HIV/AIDS | virological failure | treatment dropout | antiretroviral therapy | China | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Male | Secondary Prevention - methods | Young Adult | Anti-Retroviral Agents - administration & dosage | Treatment Failure | Adolescent | Aged, 80 and over | Adult | Female | HIV Infections - drug therapy | Aged | Antiretroviral Therapy, Highly Active - methods | Index Medicus | and Commentaries | HIV | AIDS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy
by Wijting, I.E.A and Rutsaert, S.L and Rokx, C and Burger, D.M and Verbon, A and Kampen, J. J. A. van and Rijnders, B.J.A and Vandekerckhove, L
HIV medicine, ISSN 1464-2662, 2019, Volume 20, Issue 1, pp. 63 - 68
HIV‐1 | virological failure | HIV integrase inhibitors | combination antiretroviral therapy | dolutegravir monotherapy | HIV-1 | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV Integrase Inhibitors - pharmacology | HIV-1 - drug effects | Heterocyclic Compounds, 3-Ring - pharmacology | HIV Infections - virology | Humans | Middle Aged | Male | CD4 Lymphocyte Count | HIV Infections - immunology | HIV-1 - physiology | Heterocyclic Compounds, 3-Ring - therapeutic use | Treatment Failure | HIV Integrase Inhibitors - therapeutic use | Adult | Female | HIV Infections - drug therapy | Maintenance Chemotherapy | Viral Load - drug effects | Therapy | Identification methods | Copy number | Lamivudine | Maintenance | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Antiretroviral agents | Human immunodeficiency virus--HIV | Peripheral blood mononuclear cells | Diagnosis | Deoxyribonucleic acid--DNA | Index Medicus | Short Communications | Short Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation
by Claudie Laprise and Alexandra de Pokomandy and Jean-Guy Baril and Serge Dufresne and Helen Trottier
Clinical infectious diseases, ISSN 1058-4838, 11/2013, Volume 57, Issue 10, pp. 1489 - 1496
HIV/AIDS | Antiretrovirals | HIV infections | HIV | RNA | Viremia | Health care industry | Viral load | Disease risks | Virology | Arts | Virological failure | Low-level viremia | Cohort study | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | HIV Infections - virology | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Viremia - drug therapy | Viral Load | Incidence | Viremia - virology | Treatment Failure | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Cohort Studies | Measurement | Care and treatment | Research | HIV infection | Patient outcomes | Antiretroviral drugs | Comparative analysis | Ribonucleic acid--RNA | Human immunodeficiency virus--HIV | Risk assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors
by Borghetti, A and Ciccullo, A and Lombardi, F and Baldin, G and Belmonti, S and Prosperi, M and Incardona, F and Heger, E and Borghi, V and Sönnerborg, A and Zazzi, M and De Luca, A and Di Giambenedetto, S
HIV medicine, ISSN 1464-2662, 01/2021, Volume 22, Issue 1, pp. 22 - 27
raltegravir | integrase inhibitors | virological failure | NRTI backbone | naïve | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Integrase | Emtricitabine | Backbone | RNA-directed DNA polymerase | Lamivudine | Risk | Thymidine | Ribonucleic acid--RNA | Drug resistance | Antiretroviral therapy | CD4 antigen | Tenofovir | Inhibitors | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Abacavir | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient
by Lozano, Ana Belén and Chueca, Natalia and de Salazar, Adolfo and Fernández-Fuertes, Elisa and Collado, Antonio and Fernández, Juan Manuel and Álvarez, Marta and García, Federico
Antiviral research, ISSN 0166-3542, 07/2020, Volume 179, pp. 104717 - 104717
Virological failure | R263K | Bictegravir | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected eritrean immigrant
by Bansal, Vineeta and Metzner, Karin J and Niederöst, Barbara and Leemann, Christine and Böni, Jürg and Günthard, Huldrych F and Fehr, Jan S
Emerging infectious diseases, ISSN 1080-6040, 2011, Volume 17, Issue 10, pp. 1966 - 1968
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Prognosis | HIV-1 - drug effects | HIV Infections - virology | Humans | Drug Resistance, Viral | HIV Reverse Transcriptase - genetics | HIV-1 - genetics | Antiretroviral Therapy, Highly Active | HIV Infections - diagnosis | Treatment Failure | Adult | HIV Infections - drug therapy | Mutation | Emigrants and Immigrants | Case studies | Antiviral agents | Diagnosis | Drug therapy | Health aspects | HIV infection | resource-limited setting | ART | early virological failure | HIV | antiretroviral therapy | HIV-1 subtype C | letter | Letters to the Editor | K65R | drug-resistant HIV-1 minority variants | retroviruses
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Determinants of Virological Failure Among Adult Clients on First-Line Antiretroviral Therapy in Amhara Regional State, Northeast Ethiopia. A Case--Control Study
by Mebratu, Wondwosen and Fentaw, Zinabu and Molla, Assresie and Wedajo, Shambel
HIV/AIDS (Auckland), ISSN 1179-1373, 11/2020, Volume 12, pp. 749 - 756
Antiviral agents | Highly active antiretroviral therapy | Adults | Patient compliance | Analysis | Variables | Ethics | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Data collection | Drug therapy | Public health | Antiretroviral therapy | CD4 antigen | Sociodemographics | highly active antiretroviral therapy | hiv/aids | virological failure | case-control study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Clinical outcomes after first‐line HIV treatment failure in South Africa: the next cascade of care
by Iwuji, CC and Shahmanesh, M and Koole, O and Herbst, K and Pillay, D and Siedner, MJ and Baisley, K and H-DREAM Network and the H‐DREAM Network
HIV medicine, ISSN 1464-2662, 08/2020, Volume 21, Issue 7, pp. 457 - 462
viral load monitoring | South Africa | virological failure | HIV drug resistance | antiretroviral therapy | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Disease transmission | Telemedicine | Rural areas | Antiretroviral agents | Human immunodeficiency virus--HIV | Ribonucleic acid--RNA | Patients | Public health | Morbidity | Public sector | Antiretroviral therapy | Index Medicus | Short Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients
by Teira, R and Vidal, F and Muñoz‐Sánchez, P and Geijo, P and Viciana, P and Ribera, E and Domingo, P and Castaño, M and Martínez, E and Roca, B and Puig, T and Estrada, V and Deig, E and Galindo, MJ and Fuente, B and Lozano, F and Montero, M and Muñoz‐Sanz, A and Sanchez, T and Terrón, A and Romero‐Palacios, A and Lacalle, JR and Garrido, M and Suárez‐Lozano, I and VACH Study Grp and VACH Study Group and the VACH Study Group
HIV medicine, ISSN 1464-2662, 03/2017, Volume 18, Issue 3, pp. 196 - 203
low‐level viraemia | cohort study | virological failure | HIV | residual viraemia | low-level viraemia | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Anti-Retroviral Agents - therapeutic use | Risk Assessment | Viremia | HIV Infections - virology | Humans | Middle Aged | Male | Risk | Viral Load | Incidence | Young Adult | HIV-1 - isolation & purification | Treatment Failure | Adolescent | Adult | Female | HIV Infections - drug therapy | Sustained Virologic Response | Cohort Studies | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | HIV (Viruses) | Antiretroviral drugs | Health risks | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Low level | Antiretroviral therapy | CD4 antigen | Confidence intervals | Antiretroviral agents | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe
by Judd, A and Lodwick, R and Noguera-Julian, A and Gibb, D. M and Butler, K and Costagliola, D and Sabin, C and van sighem, A and Ledergerber, B and Torti, C and Mocroft, A and Podzamczer, D and Dorrucci, M and de Wit, S and Obel, N and Dabis, F and Cozzi-Lepri, A and García, F and Brockmeyer, N. H and Warszawski, J and Gonzalez-Tome, M. I and Mussini, C and Touloumi, G and Zangerle, R and Ghosn, J and Castagna, A and Fätkenheuer, G and Stephan, C and Meyer, L and Campbell, M. A and Chene, G and Phillips, A and Mary Krause, Murielle and Leport, Catherine and Wittkop, Linda and Reiss, Peter and Wit, Ferdinand and Prins, Maria and Bucher, Heiner and Gibb, Diana and Amo, Julia Del and Thorne, Claire and Kirk, Ole and Pérez-Hoyos, Santiago and Hamouda, Osamah and Bartmeyer, Barbara and Chkhartishvili, Nikoloz and Antinori, Anea and Monforte, Antonella d'Arminio and van der Valk, Marc and Collaboration Observational HIV Ep and Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord and The Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
HIV medicine, ISSN 1464-2662, 2017, Volume 18, Issue 3, pp. 171 - 180
virological failure | young people | perinatal HIV infection | Europe | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Anti-Retroviral Agents - therapeutic use | Humans | Drug Resistance, Viral | Child, Preschool | Infant | Male | Young Adult | Time Factors | Treatment Failure | Adolescent | Adult | Female | HIV Infections - drug therapy | Population Groups | Child | Cohort Studies | Highly active antiretroviral therapy | Protease inhibitors | Proteases | DNA polymerases | HIV patients | Youth | Teenagers | Comparative analysis | HIV (Viruses) | HIV infection | Epidemiology | Risk factors | Antiretroviral drugs | Young adults | RNA-directed DNA polymerase | Data processing | Infections | Risk analysis | Ribonucleic acid--RNA | Antiretroviral therapy | CD4 antigen | Confidence intervals | Perinatal infection | Developmental stages | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Adults | Children | Adolescents | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda
by Birungi, J and Cui, Z and Okoboi, S and Kapaata, A and Munderi, P and Mukajjanga, C and Nanfuka, M and Nyonyintono, MS and Kim, J and Zhu, J and Kaleebu, P and Moore, DM
HIV medicine, ISSN 1464-2662, 01/2020, Volume 21, Issue 1, pp. 21 - 29
resource‐limited setting | reversal | adherence counselling | virological failure | HIV | Antiretroviral drugs | Therapy | RNA-directed DNA polymerase | Antiretroviral agents | Human immunodeficiency virus--HIV | Counseling | Measurement methods | Mutation | Ribonucleic acid--RNA | Drug therapy | Antiretroviral therapy | CD4 antigen | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights